Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
Go back to Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 65.07 +0.14 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.93 | 52 Week High | $5.17 | |||
| Open | $65.75 | 52 Week Low | $0.94 | |||
| Day High | $67.78 | P/E | N/A | |||
| Day Low | $64.43 | EPS | $0.00 | |||
| Volume | 2,582,827 | |||||
